Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Rectal Neoplasms × Crizotinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 19 Lymphoma 5 Lung Neoplasms 5 Multiple Myeloma 4 Lymphoma, Large-Cell, Anaplastic 4 Neuroblastoma 3 Neoplasms 2 Hematologic Neoplasms 2 Carcinoma 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Neurofibromatosis 2 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Lobular 1 Carcinoma, Large Cell 1 Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer 1 Advanced Cancer 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1 ALK-positive NSCLC 1 ALK or ROS1-positive NSCLC 1

Interventions

Oxaliplatin 49 Fluorouracil 45 Leucovorin 42 Capecitabine 40 Irinotecan 31 Bevacizumab 31 Radiotherapy 24 Cetuximab 23 Radiation 13 Panitumumab 13 Folfox protocol 10 Surgical Procedures, Operative 9 IFL protocol 8 Radiotherapy, Intensity-Modulated 6 Magnetic Resonance Spectroscopy 6 aflibercept 5 Immunohistochemistry 5 Gene Expression Profiling 5 Chemotherapy, Adjuvant 5 Fluorodeoxyglucose F18 4 Floxuridine 4 Celecoxib 4 trifluridine tipiracil drug combination 3 dehydroftorafur 3 XELOX 3 Sorafenib 3 Ramucirumab 3 Neoadjuvant Therapy 3 Erlotinib Hydrochloride 3 Drug Therapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡